Analysis of cocaine and two metabolites in dried blood spots by liquid chromatography with fluorescence detection: A novel test for cocaine and alcohol intake

Journal of Chromatography A

Volumn 1217, Issue 46, 2010, Pages 7242-7248

  Mercolini, Laura ^a   Mandrioli, Roberto ^a   Gerra, Gilberto ^b   Raggi, Maria Augusta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b United Nations Office on Drugs and Crime Austria   (Austria)

Author keywords

Cocaine; Dried blood spots (DBS); Liquid chromatography with fluorescence detection; Metabolites; Plasma

Indexed keywords

ACTIVE METABOLITES; ALCOHOL INTAKE; ANALYTES; BENZOYLECGONINE; COCAINE; DRIED BLOOD SPOTS; DRIVING UNDER THE INFLUENCE; EXTRACTION YIELD; FLUORESCENCE DETECTION; HPLC METHOD; MOBILE PHASE; PHOSPHATE BUFFERS; PLASMA SAMPLES; SAMPLE PRETREATMENT; SIMULTANEOUS ANALYSIS; SOLID-PHASE EXTRACTION; SPECTROFLUORIMETRIC;

ACETONITRILE; BIOMOLECULES; BLOOD; CHROMATOGRAPHIC ANALYSIS; COLUMN CHROMATOGRAPHY; ETHANOL; FLUORESCENCE; LIQUIDS; METABOLISM; METABOLITES; PLASMAS; SOLVENT EXTRACTION; SOLVENTS;

LIQUID CHROMATOGRAPHY;

ACETONITRILE; BENZOYLECGONINE; BUFFER; COCAINE; HOMOCOCAINE; PHOSPHATE;

ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; COCAINE DEPENDENCE; CONTROLLED STUDY; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; SOLVENT EXTRACTION; SPECTROFLUOROMETRY;

ALCOHOL DRINKING; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; DESICCATION; ETHANOL; FEMALE; HUMANS; LINEAR MODELS; MALE; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; SPECTROMETRY, FLUORESCENCE; SUBSTANCE ABUSE DETECTION;

EID: 77958111662     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2010.09.037     Document Type: Article

References (21)

1. United Nations, World Drug Report 2009, United Nation Office on Drugs and Crime, Vienna, 2009.
2. Haasen C., Prinzleve M., Zurhold H., Rehm J., Güttinger F., Fischer G., Jagsch R., Olsson B., Ekendahl M., Verster A., Camposeragna A., Pezous A.M., Gossop M., Manning V., Cox G., Ryder N., Gerevich J., Bacskai E., Casas M., Matali J.L., Krausz M. Eur. Addict. Res. 2004, 10:139.
3. Serpelloni G., Bonci A., Rimondo C. Cocaina e minori 2009, Dipartimento Politiche Antidroga, Rome.
4. Toroyan T., Peden M. Youth and Road Safety 2007, World Health Organization, Geneva.
5. Penning R., Veldstra J.L., Daamen A.P., Olivier B., Verster J.C. Curr. Drug Abuse Rev. 2010, 3:23.
6. Senna M.C., Augsburger M., Aebi B., Briellmann T.A., Donzé N., Dubugnon J.L., Iten P.X., Staub C., Sturm W., Sutter K. Forensic Sci. Int. 2010, 198:11.
7. MacDonald S., Mann R., Chipman M., Pakula B., Erickson P., Hathaway A., MacIntyre P. Traffic Inj. Prev. 2008, 9:190.
8. Couper F.J., Logan B.K. Drugs and Human Performance Fact Sheets 2004, National Highway Safety Administration, Washington.
9. Harris D.S., Everhart E.T., Mendelson J., Jones R.T. Drug Alcohol Depend. 2003, 72:169.
10. McCance-Katz E.F., Price L.H., McDougle C.J., Kosten T.R., Black J.E., Jatlow P.I. Psychopharmacology 1993, 111:39.
11. Alfazil A.A., Anderson R.A. J. Anal. Toxicol. 2008, 32:511.
12. Henderson L.O., Powell M.K., Hannon W.H., Bernert J.T., Pass K.A., Fernhoff P., Ferre C.D., Martin L., Franko E., Rochat R.W., Brantley M.D., Sampson E. Biochem. Mol. Med. 1997, 61:143.
13. Sosnoff C.S., Ann Q., Bernert J.T., Powell M.K., Miller B.B., Henderson L.O., Hannon W.H., Fernhoff P., Sampson E.J. J. Anal. Toxicol. 1996, 20:179.
14. Henderson L.O., Powell M.K., Hannon W.H., Miller B.B., Martin M.L., Hanzlick R.L., Vroon D., Sexson W.R. J. Anal. Toxicol. 1993, 17:42.
15. United States Pharmacopeial Convention United States Pharmacopeia 2009, United States Pharmacopeial Convention, Rockville. 32nd ed.
16. ICH Harmonised tripartite guideline validation of analytical procedures, text and methodology Q2(R1), ICH Secretariat, Geneva, 2005, available from: http://www.ich.org/LOB/media/MEDIA417.pdf.
17. Guidance for Industry, Bioanalytical Method Validation, U.S. Food and Drug Administration - Center for Drug Evaluation and Research (CDER), Silver Spring, 2001, available from: http://www.fda.gov/CDER/GUIDANCE/4252fnl.pdf.
18. Mercolini L., Mandrioli R., Saladini B., Conti M., Baccini C., Raggi M.A. J. Pharm. Biomed. 2008, 48:456.
19. Skopp G. Forensic Sci. Med. Pathol., 2010, Epub ahead of print 10 March 2010, doi:10.1007/s12024-010r-r9150-4.
20. Jenkins A.J., Goldberger B.A. On-site Drug Testing 2002, Humana Press, Totowa.
21. D. Isenschmidt, Unusually High Blood Benzoylecgonine Concentrations in Cases with Renal Failure, The International Association of Forensic Toxicologists (TIAFT), London, 1998, available from: http://www.tiaft.org/tiaft98/thu/t_o_12.html.